After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Vertex Pharmaceuticals, Inc is $129.62B. A total of 1.39 million shares were traded on the day, compared to an average of 1.68M shares.
In the most recent transaction, ALTSHULER DAVID bought 3,231 shares of VRTX for 510.00 per share on Mar 13 ’25. In a previous transaction on Mar 10 ’25, WAGNER CHARLES F JR sold 3,298 shares at 500.00 per share. VRTX shares that EVP & Chief Financial Officer owns now total 51,671.
Among the insiders who sold shares, Tatsis Ourania disposed of 3,242 shares on Mar 10 ’25 at a per-share price of $499.99. This resulted in the EVP, Chief Reg. & Quality Off. holding 51,239 shares of VRTX after the transaction. In another insider transaction, ALTSHULER DAVID sold 3,231 shares at $500.00 per share on Mar 10 ’25. Company shares held by the EVP, Chief Scientific Officer now total 26,512.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VRTX has a high of $519.88 and a low of $377.85.
As of this writing, VRTX has an earnings estimate of $4.32 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of $5.19 per share and a lower estimate of $3.78.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $63.87, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.10.
